Ken Griffin Inogen Inc Call Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$7.67 - $12.98 $19,175 - $32,450	2,500 Added 26.88%	11,800 $114,000
Q2 2024 Aug 14, 2024	SELL	$6.3 - $8.95 $47,880 - $68,020	-7,600 Reduced 44.97%	9,300 $75,000
Q1 2024 May 15, 2024	BUY	$5.26 - $10.15 $81,530 - $157,325	15,500 Added 1107.14%	16,900 $136,000
Q4 2023 Feb 14, 2024	SELL	$4.21 - $6.32 $13,893 - $20,856	-3,300 Reduced 70.21%	1,400 $7,000
Q3 2023 Nov 14, 2023	SELL	$5.14 - $11.28 $2,570 - $5,640	-500 Reduced 9.62%	4,700 $24,000
Q2 2023 Aug 14, 2023	BUY	$10.01 - $13.86 $30,030 - $41,580	3,000 Added 136.36%	5,200 $60,000
Q1 2023 May 15, 2023	BUY	$11.88 - $26.0 $26,136 - $57,200	2,200 New	2,200 $27,000

143

21M

119K

149K

Ticker INGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 22,866,500
Market Cap $205M
Description
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.